Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose.
D015107:4-Butyrolactone / Q000494:pharmacology; D000375:Aging; D000818:Animals; D001304:Auditory Diseases, Central / Q000378:metabolism; D001345:Autoradiography; D001786:Blood Glucose / Q000378:metabolism*; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002250:Carbon Radioisotopes; D002415:Cats; D002490:Central Nervous System / Q000378:metabolism* / Q000502:physiology; D002560:Cerebrovascular Circulation; D003837:Deoxy Sugars / Q000378:metabolism*; D003847:Deoxyglucose / Q000378:metabolism*; D004285:Dogs; D004594:Electrophysiology; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D008253:Macaca mulatta; D009020:Morphine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000378:metabolism; D012584:Sciatic Nerve / Q000378:metabolism; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D013874:Thiopental; D014793:Visual Cortex / Q000378:metabolism / Q000502:physiology
D001786:Blood Glucose; D002250:Carbon Radioisotopes; D003837:Deoxy Sugars; D011954:Receptors, Dopamine; D009020:Morphine; D003847:Deoxyglucose; D013874:Thiopental; D015107:4-Butyrolactone